291 related articles for article (PubMed ID: 29687317)
21. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.
Böhm M; Komajda M; Borer JS; Ford I; Maack C; Tavazzi L; Moyne A; Swedberg K;
Eur J Heart Fail; 2018 Feb; 20(2):373-381. PubMed ID: 29027329
[TBL] [Abstract][Full Text] [Related]
22. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
Lan WR; Lin SI; Liao FC; Chang HY; Tsai CT; Wu YJ; Liu PY; Chen CH; Lee YH
Am J Cardiol; 2021 Jul; 150():77-81. PubMed ID: 34006371
[TBL] [Abstract][Full Text] [Related]
23. Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction.
Pay L; Yumurtaş AÇ; Tezen O; Çetin T; Keskin K; Eren S; Çinier G; Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
Rev Assoc Med Bras (1992); 2023; 69(12):e20230703. PubMed ID: 37971125
[TBL] [Abstract][Full Text] [Related]
24. Advances in the management of heart failure: the role of ivabradine.
Müller-Werdan U; Stöckl G; Werdan K
Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
[TBL] [Abstract][Full Text] [Related]
25. Optimizing heart rate with ivabradine in heart failure with reduced ejection fraction: Insights from a post-hoc analysis of the SHIFT trial.
Joury A
Eur J Heart Fail; 2023 Aug; 25(8):1436-1438. PubMed ID: 37370184
[No Abstract] [Full Text] [Related]
26. Expert Consensus on Ivabradine-based Therapy for Heart Rate Management in Chronic Coronary Syndrome and Heart Failure with Reduced Ejection Fraction in India.
Mohan JC; Sathyamurthy I; Panja M; Agarwala R; Ponde CK; Kumar AS; Mahala BK; Kolapkar V; Kumar RVL; Patel K
Curr Cardiol Rev; 2023; 19(5):97-106. PubMed ID: 36941812
[TBL] [Abstract][Full Text] [Related]
27. Ivabradine: Heart Failure and Beyond.
Chaudhary R; Garg J; Krishnamoorthy P; Shah N; Lanier G; Martinez MW; Freudenberger R
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):335-43. PubMed ID: 26721645
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
[No Abstract] [Full Text] [Related]
29. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
[TBL] [Abstract][Full Text] [Related]
30. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
Foster JL; Bobadilla RV
J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
[TBL] [Abstract][Full Text] [Related]
31. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Hidalgo FJ; Anguita M; Castillo JC; Rodríguez S; Pardo L; Durán E; Sánchez JJ; Ferreiro C; Pan M; Mesa D; Delgado M; Ruiz M
Int J Cardiol; 2016 Aug; 217():7-11. PubMed ID: 27167103
[TBL] [Abstract][Full Text] [Related]
32. Optimal Heart Rate Modulation Using Ivabradine.
Imamura T; Kinugawa K
Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
[TBL] [Abstract][Full Text] [Related]
33. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
Imamura T; Kinugawa K
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
[TBL] [Abstract][Full Text] [Related]
34. Ivabradine for the treatment of chronic heart failure.
Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of Ivabradine and the Effect on Chronic Heart Failure.
Zhou Y; Wang J; Meng Z; Zhou S; Peng J; Chen S; Wang Q; Sun K
Curr Top Med Chem; 2019; 19(21):1878-1901. PubMed ID: 31400267
[TBL] [Abstract][Full Text] [Related]
36. Effect of Early Treatment With Ivabradine Plus Beta-blockers on Long-term Outcomes in Patients Hospitalized With Systolic Heart Failure.
Hidalgo F; Carrasco F; Castillo JC; Anguita M
Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1086-1088. PubMed ID: 29373253
[No Abstract] [Full Text] [Related]
37. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
[TBL] [Abstract][Full Text] [Related]
38. [Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and health related quality of life: results from the SHIFT substudies].
Vítovec J; Spinarová L; Spinar J
Vnitr Lek; 2012; 58(7-8):612-17. PubMed ID: 23067195
[TBL] [Abstract][Full Text] [Related]
39. Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction.
Huang D; Chan PH; Lam CC; Shea PC; Yiu KH; Tse HF; Siu CW
J Heart Valve Dis; 2015 Jul; 24(4):433-5. PubMed ID: 26897811
[TBL] [Abstract][Full Text] [Related]
40. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
